|
MLF1IP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.66133814775094E-16 |
| Normal-vs-Stage2 |
1.968150E-02 |
| Normal-vs-Stage3 |
9.10459999947655E-07 |
| Normal-vs-Stage4 |
4.157300E-03 |
| Stage1-vs-Stage2 |
3.685800E-01 |
| Stage1-vs-Stage3 |
6.959600E-03 |
| Stage1-vs-Stage4 |
7.081900E-02 |
| Stage2-vs-Stage3 |
5.489800E-01 |
| Stage2-vs-Stage4 |
4.985400E-01 |
| Stage3-vs-Stage4 |
7.226600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.53147999999437E-05 |
| Normal-vs-Asian |
1.382360E-02 |
| Caucasian-vs-AfricanAmerican |
5.112600E-01 |
| Caucasian-vs-Asian |
3.094400E-01 |
| AfricanAmerican-vs-Asian |
6.710000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
4.24680002275579E-09 |
| Male-vs-Female |
2.626200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.19860000205685E-08 |
| Normal-vs-Extreme_Weight |
1.12687636999453E-13 |
| Normal-vs-Obese |
1.55719992456227E-10 |
| Normal-vs-Extreme_Obese |
6.521600E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.321220E-01 |
| Normal_Weight-vs-Obese |
6.683000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.517200E-03 |
| Extreme_Weight-vs-Obese |
2.240600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.243600E-02 |
| Obese-vs-Extreme_Obese |
3.260800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.095660E-02 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
5.41910960549785E-12 |
| Normal-vs-Age(81-100Yrs) |
5.502000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.813800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.957780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.548650E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.395600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.691400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.307600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.44089209850063E-16 |
| Normal-VS-Type2 PRCC |
6.57629950495675E-10 |
| Normal-VS-KIRP CIMP |
5.744000E-03 |
| Normal-VS-Unclassified PRCC |
3.29899999540473E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.698800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.533900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.207600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.596400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.647400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.103500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.66689999999692E-05 |
| Normal-vs-N1 |
7.98560000000448E-05 |
| Normal-vs-N2 |
1.015590E-01 |
| N0-vs-N1 |
2.196200E-02 |
| N0-vs-N2 |
5.047000E-01 |
| N1-vs-N2 |
5.476600E-01 |
|
|
